Offer was a 29% increase to Kite's closing price on Friday....
I've read that this is a new class of drug but to be used in the field on oncology and will be used with other immunotherapies.
Hoping that this is a good sign for Cavatak and VLA and there is still a huge appetite for cancer therapies!
- Forums
- ASX - By Stock
- Gilead buys Kite Pharma for $11.9 BN
Offer was a 29% increase to Kite's closing price on Friday.......
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)